Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics ( (AU:ATH) ) has issued an announcement.
Alterity Therapeutics Limited announced a proposed issue of 1,666,666,663 ordinary fully paid securities, with the issue date set for September 15, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s financial standing and market position by increasing its capital base, which may support ongoing research and development efforts.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on the development of therapeutic products for neurodegenerative diseases. The company is primarily involved in creating treatments for conditions like Alzheimer’s and Parkinson’s disease, aiming to address unmet medical needs in these areas.
YTD Price Performance: 30.0%
Average Trading Volume: 13,758,518
Technical Sentiment Signal: Sell
Current Market Cap: A$119.7M
For an in-depth examination of ATH stock, go to TipRanks’ Overview page.